Rapport Therapeutics, Inc. Common Stock (RAPP) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RAPP. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 152 institutions reported holding RAPP, with 51.3 million shares worth $2.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 7,172,894 | $299M | INCREASED |
| Trv GP V | 6,280,525 | $262M | DECREASED |
| Arch Venture Management | 3,728,738 | $155M | UNCHANGED |
| Capital Group | 3,473,615 | $145M | DECREASED |
| Goldman Sachs | 2,910,449 | $121M | DECREASED |
Full institutional holdings, insider history, and congressional trades for Rapport Therapeutics, Inc. Common Stock on SentiSense.